Compare ImmunityBio Inc. Common Stock (IBRX) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Victoria's Secret & Co — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while Victoria's Secret & Co trades at $87.3 (market cap $6.91B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 1,346,928). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Victoria's Secret & Co for 34 Days on average.
| IBRX | VSXY | |
|---|---|---|
Market Cap | $10.51B | $6.91B |
Volume | 10,445,785 | 1,346,928 |
Sector | Health | Consumer Cyclical |
52-Week High | $11.55 | $99.97 |
52-Week Low | $1.98 | $28.25 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $10.97B | $9.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Victoria's Secret (VSXY) trades at $85.79, up 0.83% today, with a bullish technical trend and strong analyst support. Recent earnings beats and a 60% buy rating from analysts highlight improving fundamentals, while the stock shows robust profitability with a 45.27% ROE. The company's 2026 revenue guidance raise and global expansion efforts signal positive momentum, though valuation remains elevated with a P/E of 19.15.
The outlook for VSXY is positive, driven by earnings growth and brand revitalization, but risks include rich valuation and competitive pressures. Upside to the $86.80 consensus target appears achievable if execution continues, yet investors face margin volatility and macroeconomic sensitivity in the retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
